国际眼科纵览 ›› 2026, Vol. 50 ›› Issue (3): 172-178.doi: 10.3760/cma.j.cn115500-20251031-26302

• 综述 • 上一篇    下一篇

眼类器官的基础研究与临床前研究

向梓瀚1, 2  滕旭1   

  1. 1 首都医科大学基础医学院生物化学与分子生物学系,北京 100069; 2 首都医科大学附属北京同仁医院,北京 100730
  • 收稿日期:2025-10-31 出版日期:2026-06-22 发布日期:2026-06-22
  • 通讯作者: 滕旭,Email:tengxu@ccmu.edu.cn
  • 基金资助:
    国家自然科学基金面上项目(82273403、42277420);首都医科大学本科生科研训练项目(D2KT2023042)

Basic research and preclinical studies on ocular organoids

Xiang Zihan1, 2, Teng Xu1   

  1. Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China; 2 Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
  • Received:2025-10-31 Online:2026-06-22 Published:2026-06-22
  • Contact: Teng Xu, Email: tengxu@ccmu.edu.cn
  • Supported by:
    National Natural Science Foundation of China General Program (82273403, 42277420); Capital Medical University Undergraduate Research Training Program (D2KT2023042)

摘要: 类器官作为可模拟原生器官复杂结构和生理功能的体外三维多细胞微模型,已成为生命科学和转化医学领域的重要工具。眼类器官通过体外重构三维人眼组织搭建了眼部疾病机制研究、药物筛选及再生医学等领域的关键研究平台。近年来,眼类器官技术成功在体外重现了视网膜、角膜等多种眼组织的发育过程和复杂结构,推动了相关基础研究和临床转化。本文系统总结这些技术方案的进展,包括多种细胞来源培养方案、创新诱导方法以及新兴医工结合技术的优化策略,综述其在疾病模拟、药物研发和再生医学中的临床应用前景,剖析当前研究存在的异质性控制、复杂结构再现及规模化生产的挑战和未来发展方向,为眼类器官领域的后续发展与创新提供参考。

关键词: 眼类器官, 人工智能, 3D生物打印, 微流控芯片

Abstract: Organoids, as three\|dimensional in vitro multicellular micro\|models that recapitulate the complex structure and physiological functions of native organs, have become essential tools in life sciences and translational medicine. Ocular organoids, by reconstructing three\|dimensional human ocular tissues in vitro, provide a critical platform for investigating the mechanisms of ocular diseases, drug screening, and regenerative medicine. In recent years, ocular organoid technology has successfully replicated the developmental processes and complex structures of various ocular tissues, such as the retina and cornea, thereby advancing both fundamental research and clinical translation. This article systematically summarizes the technical advances in this field, including culture protocols for multiple cell sources, innovative induction strategies, and emerging engineering\|medical integration approaches for optimization. It further reviews the clinical applications prospects of eye organoids in disease modeling, drug development, and regenerative medicine. In addition, the challenges currently faced in the field—such as heterogeneity control, complex structural recapitulation, and large\|scale production—as well as future directions are discussed, providing a reference for further progress and innovation in this area.

Key words: Eye organoid, Artificial intelligence, 3D bioprinting, Microfluidic organ-on-a-chip